wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34180815-00D78A1E-4093-43E7-924B-BB3359B99C50
Q34180815-00D78A1E-4093-43E7-924B-BB3359B99C50
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34180815-00D78A1E-4093-43E7-924B-BB3359B99C50
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib.
P2860
Q34180815-00D78A1E-4093-43E7-924B-BB3359B99C50
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34180815-00D78A1E-4093-43E7-924B-BB3359B99C50
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
72c2b5c2d3b313448404e03b05426356f1481c41
P2860
Personalizing therapy in an epidermal growth factor receptor-tyrosine kinase inhibitor-resistant non-small-cell lung cancer using PF-00299804 and trastuzumab.